In more slowly developing tumor models, e.g., the DEN or the GrM1 model, we are currently following the hypothesis that NK cells are key cells in delivering the “spark” that could be a main denominator for setting the stage for induction of a full scale response involving all appropriate cell types necessary for an anti-cancer immune attack: most importantly dendritic cells and T cells. Here, GRM1 is linked to neoplasm.